LifeArc at BIO-Europe 2026
Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website
LifeArc takes part in 2 sessions at BIO-Europe 2026 in Cologne. Its sessions span biotech governance and cardiometabolic medicine. One looks at power dynamics and building trust with senior stakeholders at the board table, and another asks where cardiometabolic treatment stands beyond GLP-1 drugs.
| Organization | BIO-Europe 2026 Attendance |
|---|---|
LifeArc London, United Kingdom | |
UK medical research charity that funds translational research and invests in early-stage life sciences companies through LifeArc Ventures. | Panel Tue Nov 10 16:00–16:45 At the Board Table: Navigating Power Dynamics and Building Senior Stakeholder Trust (In collaboration with YVC) How younger executives and junior investors on biotech boards can earn senior members' trust and help drive decisions. Panel Tue Nov 10 10:00–10:45 Cardiometabolic innovations beyond GLP-1 – Where are we now? Which drug approaches beyond GLP-1 medicines are drawing attention for obesity, diabetes and heart disease risk, and where money and partnerships are going. |
Instantly find 20 buyers from LifeArc
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by EBD Group, Informa Connect or BIO-Europe. Submit a correction